Skip to main content
. 2021 Feb 20;11(9):4232–4250. doi: 10.7150/thno.49819

Figure 8.

Figure 8

Graphical abstract. Loss of SPTBN1 increases p65 protein stability via the inhibition of SOCS1 and enhances NF-κB activation, stimulating inflammatory responses and immune-suppressive conditions for the formation and progression of liver cancer.